Cao L - Search Results

1

LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.

Ge P, Cao L, Zheng M, Yao Y, Wang W, Chen X. Ge P, et al. Among authors: cao l. Exp Mol Pathol. 2021 Jun;120:104633. doi: 10.1016/j.yexmp.2021.104633. Epub 2021 Mar 19. Exp Mol Pathol. 2021. PMID: 33753110

2

miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer.

Ge P, Cao L, Chen X, Jing R, Yue W. Ge P, et al. Among authors: cao l. BMC Cancer. 2019 Dec 10;19(1):1203. doi: 10.1186/s12885-019-6416-4. BMC Cancer. 2019. PMID: 31823748 Free PMC article.

3

lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p-SIX1 axis.

Ge P, Cao L, Yao YJ, Jing RJ, Wang W, Li HJ. Ge P, et al. Among authors: cao l. Onco Targets Ther. 2019 Jul 30;12:6105-6117. doi: 10.2147/OTT.S197454. eCollection 2019. Onco Targets Ther. 2019. PMID: 31534348 Free PMC article.

4

Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.

Li W, Cao L, Chen X, Lei J, Ma Q. Li W, et al. Among authors: cao l. Oncol Rep. 2016 Mar;35(3):1718-26. doi: 10.3892/or.2015.4504. Epub 2015 Dec 22. Oncol Rep. 2016. PMID: 26707376

5

Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.

Cao L, Chen X, Xiao X, Ma Q, Li W. Cao L, et al. Int J Oncol. 2016 Aug;49(2):735-43. doi: 10.3892/ijo.2016.3559. Epub 2016 Jun 3. Int J Oncol. 2016. PMID: 27278736

6

LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia.

Du X, Liu H, Yang C, Shi X, Cao L, Zhao X, Miao Y, Zhu H, Wang L, Xu W, Li J, Fan L. Du X, et al. Among authors: cao l. Leuk Res. 2021 Nov;110:106706. doi: 10.1016/j.leukres.2021.106706. Epub 2021 Sep 9. Leuk Res. 2021. PMID: 34563944

7

Novel compound ZCJ14, a gefitinib analog, exhibited prominent anti-cancer effect among several cancer cell lines.

Wang J, Yan PP, Wang HY, Zuo SJ, Zhang SQ, Cao YX, Cao L. Wang J, et al. Among authors: cao yx, cao l. Life Sci. 2022 Oct 15;307:120875. doi: 10.1016/j.lfs.2022.120875. Epub 2022 Aug 10. Life Sci. 2022. PMID: 35963298

8

Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway.

Cao L, Liu J, Zhang L, Xiao X, Li W. Cao L, et al. Oncol Rep. 2016 Oct;36(4):2245-51. doi: 10.3892/or.2016.5044. Epub 2016 Aug 25. Oncol Rep. 2016. PMID: 27572503

9

miR-4319 Suppresses the Growth of Esophageal Squamous Cell Carcinoma Via Targeting NLRC5.

Hu X, Wang M, Cao L, Cong L, Gao Y, Lu J, Feng J, Shen B, Liu D. Hu X, et al. Among authors: cao l. Curr Mol Pharmacol. 2020;13(2):144-149. doi: 10.2174/1874467212666191119094636. Curr Mol Pharmacol. 2020. PMID: 31746301

10

A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer.

Wang J, Wang HY, Shen Y, Liang D, Wang HY, Zhang SQ, Cao YX, Cao L. Wang J, et al. Among authors: cao yx, cao l. Anticancer Drugs. 2019 Oct;30(9):900-908. doi: 10.1097/CAD.0000000000000788. Anticancer Drugs. 2019. PMID: 30913062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,016 results

Search Page

Filters